laboratory developed test

Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction

Labcorp’s $239 million offer was selected as the winning bid for the assets of genetic testing company Invitae, which filed for bankruptcy protection earlier this year. The acquisition deal, Labcorp's second in the past month, will enable it to expand in oncology and rare diseases.

By Frank Vinluan

MedCity News eNewsletter, Diagnostics

Other diagnostic companies utilize regulatory loopholes, not just Theranos

Several diagnostic companies use the "laboratory developed test" loophole to avoid regulation and market tests without FDA approval, for better or worse.

By Nicole Oran

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.